PB2071: SENSITIVITY OF MULTIPLE MYELOMA TO MELFLUFEN ASSOCIATES WITH DECREASED P53 ACTIVITY AND ENRICHMENT OF DNA DAMAGE REPAIR PATHWAY GENES
Juho Miettinen,
Philipp Sergeev,
Sadiksha Adhikari,
Maiju-Emilia Huppunen,
Minna Suvela,
Ana Slipicevic,
Nina N Nupponen,
Klara Acs,
Fredrik Lehmann,
Caroline Heckman
Affiliations
Juho Miettinen
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
Philipp Sergeev
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
Sadiksha Adhikari
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
Maiju-Emilia Huppunen
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
Minna Suvela
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
Ana Slipicevic
2 Oncopeptides AB, Stockholm, Sweden
Nina N Nupponen
2 Oncopeptides AB, Stockholm, Sweden
Klara Acs
2 Oncopeptides AB, Stockholm, Sweden
Fredrik Lehmann
2 Oncopeptides AB, Stockholm, Sweden
Caroline Heckman
1 Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland
